Breaking News
July 19, 2018 - Deleting single gene in gut bacteria affects metabolism, reduces weight gain in mice
July 19, 2018 - Study finds major discrepancies in prescription drug labeling pregnancy information across four countries
July 19, 2018 - Cellectar’s CLR 131 Receives FDA Orphan Drug Designation for Treatment of Ewing’s Sarcoma
July 19, 2018 - Watching the immune system in action reveals what happens when things goes wrong
July 19, 2018 - Increasing blood sugar levels improves memory and performance in older adults
July 19, 2018 - Connection between self-regulation and obesity appears to be different for girls and boys
July 19, 2018 - Researchers develop new, less destructive method for whitening teeth
July 19, 2018 - Revving up innate control of viral infection requires a three-cell ignition
July 19, 2018 - Inaccurate direct-to-consumer raw genetic data can harm patients, new research suggests
July 19, 2018 - Weight loss surgery is effective under the right situations
July 19, 2018 - BioTek awarded patent for autofocus feature on microplate reader
July 19, 2018 - Low-carb diets reduce stiffness of arteries in women and promote weight loss in men
July 19, 2018 - New review examines cannabinoids’ potential for direct treatment of cancer
July 19, 2018 - Allergic responses may help protect the skin against cancer, research suggests
July 19, 2018 - Inappropriate Prescribing of Abx High in Urgent Care Centers
July 19, 2018 - Many at risk for HIV despite lifesaving pill
July 19, 2018 - Tips for doctors and parents on the harms of marijuana use for teens
July 18, 2018 - Researchers detect presence of IgE antibodies after kidney transplantation
July 18, 2018 - New technique allows researchers to create large scale, personalized bone grafts
July 18, 2018 - Smoking May Boost Atrial Fibrillation Risk
July 18, 2018 - Genome editing method targets AIDS virus
July 18, 2018 - These things matter: Medical complications are not inevitable, a physician writes
July 18, 2018 - Cognitive functions often wilt as water departs the body, shows study
July 18, 2018 - Origins of bread found 14,400 years ago in Jordan
July 18, 2018 - Low-dose ketamine found to be as effective as opioids for treating acute pain
July 18, 2018 - Novel bioengineering technique could help repair bone defects
July 18, 2018 - Researchers identify new potential target protein for colon cancer
July 18, 2018 - Air pollution contributes significantly to diabetes globally
July 18, 2018 - Cell membrane’s importance offers new strategy to fight infections
July 18, 2018 - Researchers identify key protein involved in irregular brain cell activity
July 18, 2018 - 3D modeling of drug resistance could lead to more effective cancer treatment
July 18, 2018 - Hunger hormones could be key to new treatments for drug, alcohol addiction
July 18, 2018 - Nitrate-cured meats may contribute to mania, study finds
July 18, 2018 - Why men may recover more quickly from influenza infections than women
July 18, 2018 - Study finds discharge against medical advice as predictor of readmissions in heart attack patients
July 18, 2018 - KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD
July 18, 2018 - Self-control and obesity: Gender matters in children
July 18, 2018 - Bioengineers, diabetes researchers convene to discuss future concepts for precision medicine
July 18, 2018 - New findings support more conservative use of ED neuroimaging for non-index seizures
July 18, 2018 - Practicing yoga benefits pregnant women, study suggests
July 18, 2018 - New strategy may lead to more accurate breast cancer diagnoses
July 18, 2018 - FDA Approves Symtuza (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection
July 18, 2018 - New guide helps hospitals pick right partner to handle hospitalist services
July 18, 2018 - Deep data dive helps predict cerebral palsy
July 18, 2018 - Stricter firearm legislation associated with reduced murder and suicide rates
July 18, 2018 - Physical and sexual abuse in childhood associated with endometriosis risk
July 18, 2018 - Omega 3 supplements do not reduce risk of heart disease, stroke or death
July 18, 2018 - GSA’s new publication provides support for safe use of OTC analgesics by older adults
July 18, 2018 - Researchers receive grant from U.S. Department of Education to study children with HFASD
July 18, 2018 - Early childhood adversity increases sensitivity of the body’s immune response to cocaine
July 18, 2018 - Parental incarceration affects health behaviors of children in adulthood
July 18, 2018 - Researchers find that yellow fever and Asian tiger mosquitoes can carry new virus
July 18, 2018 - Two Regimens Fail to Stop Declines in β-Cell Function
July 18, 2018 - Researchers apply computing power to track the spread of cancer
July 18, 2018 - Olfactory receptors play pathophysiological role in all organs than merely smell perception
July 18, 2018 - Fish consumption associated with lower risk of early death
July 18, 2018 - MR Solutions’ 7T MRI imaging system installed at University of Hawaii
July 18, 2018 - Humorous ads screened around World Cup game achieve higher biometric response than sporty ads
July 18, 2018 - New study demonstrates little effect of hormone therapy on artery thickness
July 18, 2018 - A 3-Pronged Plan to Cut Type 2 Diabetes Risk
July 18, 2018 - New clues to sepsis may speed diagnosis
July 18, 2018 - Stars of Stanford Medicine: Improving cardiovascular health in Africa and beyond
July 18, 2018 - Heart attack risk continues to increase among pregnant women, study finds
July 18, 2018 - Few tips to help avoid sunburns in summer
July 18, 2018 - High-fat diet and systemic inflammation contribute to progression of prostate cancer
July 18, 2018 - Researchers develop 3D map of gene interactions that play key role in heart disease
July 18, 2018 - Conservative management of lung subsolid nodules reduces overtreatment and unnecessary surgery
July 18, 2018 - Report warns of dog illness that can spread to owners
July 18, 2018 - A winning essayist’s tips for keeping track of scientific facts
July 18, 2018 - Researchers seek to understand role of APOE mutation in Alzheimer’s disease
July 18, 2018 - Animal studies reveal brain changes responsible for appetite effects of cannabis
July 18, 2018 - New ZEISS ZEN Intellesis machine allows segmentation of correlative microscopy
July 18, 2018 - Study findings highlight importance of early detection of SMA through newborn screening
July 18, 2018 - Results of Phase III (PIX306) Trial Evaluating Progression-Free Survival of Pixuvri (pixantrone) Combined with Rituximab in Patients with Aggressive B-cell Non-Hodgkin Lymphoma
July 18, 2018 - Diabetes researchers find switch for fatty liver disease
July 18, 2018 - The future of the microbiome: A conversation
July 18, 2018 - States attacking ACA would hurt most if shield on preexisting conditions were axed
July 18, 2018 - Novel delivery system for bacteriophages could offer new way to battle lung infections
July 18, 2018 - PTSD may increase risk of stroke, heart attack in World Trade Center response crews
July 18, 2018 - Finding the right protective eyewear for young athletes
Including Drug to Same old Care Would possibly Extend Lymphoma Survival

Including Drug to Same old Care Would possibly Extend Lymphoma Survival

image_pdfDownload PDFimage_print

HealthDay news image

WEDNESDAY, Sept. 27, 2017 (HealthDay Information) — Lengthy-term remedy with the drug rituximab (Rituxan) might lengthen the lives of a few sufferers with an extraordinary type of blood most cancers, a brand new medical trial unearths.

The illness, referred to as mantle-cell lymphoma, is usually incurable. However quite a lot of therapies can extend other people’s lives. Some sufferers, as an example, are in a position to go through chemotherapy to wipe out the most cancers cells, adopted by way of a stem cellular transplant — to revive customary blood cells.

However whilst that means will also be efficient for some time, maximum sufferers see the most cancers come again.

So the brand new trial, funded by way of Rituxan maker Roche, checked out whether or not an extra step may assist: Having sufferers take Rituxan for 3 years following their stem cellular transplant.

Total, researchers discovered, the strategy did enhance sufferers’ outlook. After 4 years, 83 p.c of rituximab sufferers had been nonetheless alive and progression-free — as opposed to 64 p.c of sufferers who had same old remedy on my own.

Professionals mentioned the findings must have a direct have an effect on on sufferers’ remedy.

“This must be regarded as a brand new same old of care,” mentioned Dr. Anas Younes, leader of the lymphoma carrier at Memorial Sloan Kettering Most cancers Middle, in New York Town.

Alternatively, there are considerations with the long-term use of rituximab, consistent with Younes, who wasn’t concerned within the learn about.

The drug suppresses the immune device, so infections are at all times a possibility, he famous.

“However,” Younes added, “the advantages appear to outweigh the dangers.”

Dr. Steven Le Gouill, of Nantes Scientific College, in France, led the learn about.

He agreed that “rituximab repairs” — the usage of it long-term, after a stem cellular transplant — must turn into a brand new same old.

“The achieve in the case of total survival must inspire hematologists to prescribe rituximab repairs for transplanted sufferers,” Le Gouill mentioned.

Mantle-cell lymphoma is one in every of about 70 subtypes of non-Hodgkin lymphoma, consistent with the Leukemia & Lymphoma Society. In the USA, about four,200 individuals are identified with the illness every 12 months — maximum regularly, older males.

Medical doctors have lengthy used rituximab to regard sure cancers, together with mantle-cell lymphoma. The drug is a lab-engineered antibody that latches onto a protein on white blood cells (lymphocytes) known as B cells; the ones are the cells which are affected in mantle-cell lymphoma.

Because it stands, rituximab is used in conjunction with high-dose chemotherapy medicine to wipe out the cancerous B cells. Some sufferers then go through an “autologous” stem cellular transplant. That implies they’ve a few of their very own blood-forming stem cells got rid of prior to their drug routine; in a while, the stem cells are infused again into the frame, to revive new, wholesome blood cells.

Some sufferers — together with those that are older and frail — can not have a transplant.

However different analysis has proven that rituximab repairs, given after same old drug remedy to power out the most cancers, can lengthen the ones sufferers’ lives, Younes mentioned.

The brand new findings display the similar is correct for sufferers who do have a transplant.

The trial concerned 299 sufferers who had been more youthful than 66 once they had been identified with mantle-cell lymphoma. All underwent same old drug remedy, with rituximab and chemotherapy. Maximum — 86 p.c — spoke back neatly sufficient to go through a stem cellular transplant.

Part of the sufferers had been then randomly assigned to a few years of rituximab repairs remedy, receiving IV infusions of the drug each two months. The remaining had been adopted up with same old care.

After 4 years, 89 p.c of rituximab sufferers had been nonetheless alive, in comparison with 80 p.c within the comparability staff, the investigators discovered.

The rituximab sufferers had been additionally much more likely to stay freed from a most cancers relapse, or severe negative effects — together with critical infections and allergies: That was once true of 79 p.c of rituximab sufferers, as opposed to 61 p.c of sufferers on same old care.

In line with Le Gouill, “Rituximab repairs after stem cellular transplant is one new weapon within the arsenal to struggle towards mantle-cell lymphoma.”

He famous that different therapies were lately authorized — oral medicine that focus on abnormalities at the most cancers cells — whilst nonetheless others are in construction.

Like different antibody medicine, rituximab is pricey — operating 1000’s of greenbacks per thirty days after medical institution fees, consistent with a printed record. Repayment “might be a topic in some nations,” Le Gouill famous.

However, he added, the associated fee needs to be weighed towards the truth that the drug lengthens sufferers’ lives and has “low toxicity.”

Younes mentioned that the “vital message” from the findings is that sufferers’ survival time is constant to enhance.

The learn about findings had been printed Sept. 28 within the New England Magazine of Medication.

SOURCES: Steven Le Gouill, M.D., Ph.D., hematology carrier, Nantes Scientific College, Nantes, France; Anas Younes, M.D., leader, lymphoma carrier, Memorial Sloan Kettering Most cancers Middle, New York Town; Sept. 28, 2017, New England Magazine of Medication

Information tales are written and equipped by way of HealthDay and don’t replicate federal coverage, the perspectives of MedlinePlus, the Nationwide Library of Medication, the Nationwide Institutes of Well being, or the U.S. Division of Well being and Human Products and services.

Tagged with:

About author

Related Articles